Nursing news graphic

Nobel Prize for Hep C Discovery & CDC Says Airborne Coronavirus Possible

This week in Clipboard Health’s Nursing News round-up … 

CDC Revises Coronavirus Guidelines, Virus May Sometimes Spread via Airborne Transmission

The U.S. Centers for Disease Control and Prevention released an update to its COVID-19 transmission guidance, saying that the virus may sometimes spread via airborne transmission as the virus can “linger in the air for minutes to hours.”

Last month, the CDC quickly retracted a similar update to its guidance addressing the airborne transmission of coronavirus particles, saying it was just a draft that was mistakenly released.

WHO Estimates 1 of 10 People Worldwide Have Had COVID-19

One of the World Health Organization’s top officials estimated that 10% of the worldwide population has contracted the coronavirus. The official cautioned that the world is still at risk as 10 countries make up about 70% of the total cases of infections. 

Nobel Prize in Medicine Awarded to Trio for Hepatitis C Virus 

nursing news lightbulb icon

A trio of scientists from the United Kingdom and the United States were awarded the Nobel Prize in Medicine for their work in identifying the Hepatitis C virus. The three scientists — Harvey J. Alter, Michael Houghton, and Charles M. Rice — all did research to identify and isolate the Hepatitis C virus to prove that it was a separate infection-causing virus from Hepatitis A and B.

U.S. Stalls on New Vaccine Approval Guidelines

nursing news icon - a vaccine

New guidelines governing the approval of vaccines in the United States are being held up as the White House determines whether or not to sign off on the new Food and Drug Administration’s drafted guidelines. The biotech industry, which includes many of the U.S. developers currently developing coronavirus vaccines, has urged the government to publish and make public the guidelines. 

These guidelines set clinical trial and safety criteria for vaccine developers and would improve the overall safety of the vaccine approval process. 

Medical Studies Roundup

nursing news icon - exclamation

Here’s a brief roundup of recent medical studies and their findings for you to stay up-to-date with the ever-evolving field of medical research.

  • Americans report that they are drinking alcohol 14% more during the pandemic than they had before. Women, in particular, reported that they were drinking 41% more during spring 2020 compared to spring 2021.
  • The U.S. Centers for Disease Control and Prevention said last week that adults can get a similar type of multisystem inflammatory syndrome that children have been known to get as a result of an otherwise non-symptomatic COVID-19 infection. The syndrome in children is called MIS-C, and in adults, it is now being classified as MIS-A.
  • A new study indicates that about 82% of hospitalized COVID-19 patients experience some sort of neurological symptoms, such as headaches or altered brain functions.
  • Researchers have found that getting the common cold may help boost the immune system and protect against COVID-19. 
  • South Korean researchers have developed a COVID-19 test that can diagnose the disease in as quickly as 30 minutes.
  • The U.S. Food and Drug Administration approves a new ear infection treatment. The new treatment is a one-time single dose that doesn’t require refrigeration, unlike the previous standard for treatments, which is multiple doses over many days. 
  • New research has found that women are more likely to engage in preventative behaviors against COVID-19 compared to men. 

Race for the Vaccine: Coronavirus Vaccine Updates

Read more about the most recent updates from the past week on COVID-19 vaccine development. Russia expects to approve its second coronavirus vaccine by mid-October as it fast-tracks the approval process.

Covid-19 vaccine status tracker stages
Covid-19 vaccine tracker - regulatory review

Moderna released results from one of its early vaccine trials, targeted on older adults, that indicate the company’s vaccine candidate worked to trigger an antibody response similar to younger adults. 

Covid-19 vaccine tracker - phase 1

Thailand moves its vaccine candidate into Phase I trials

Covid-19 vaccine tracker - phase 2

Moderna and Pfizer attempt to recruit more Black volunteers into their vaccine trials. 

Covid-19 vaccine tracker - phase 3

Moderna slows its recruitment for its Phase III trials, citing difficulty in recruiting sufficient volunteers who are Black, Latino, and Native American.